Clinical Significance of Obstructive Changes in The Coronary Arteries and Clinical Manifestations of Heart Failure in Patients After Myocardial Infarction

G.T.  Madjidova; G. I.  Sunnatova; Xudoyberdiyev  A. A; Xoliqulova  M. M; Umarova  N. T.

doi:10.51699/cajmns.v7i1.3046

G.T. Madjidova Samarkand State Medical University, Department of Internal Medicine, 2nd Assistant, Samarkand, Uzbekistan.
G. I. Sunnatova Zarmed Medical University, Department of Internal Medicine, 2nd Assistant, Samarkand, Uzbekistan.
Xudoyberdiyev A. A Doctor's Office, Samarkand Branch of the Republican Scientific Center for Urgent Ambulance, Samarkand, Uzbekistan.
Xoliqulova M. M Doctor's Office, Samarkand Branch of the Republican Scientific Center for Urgent Ambulance, Samarkand, Uzbekistan
Umarova N. T. Doctor's Office, Samarkand Branch of the Republican Scientific Center for Urgent Ambulance, Samarkand, Uzbekistan.

DOI: https://doi.org/10.51699/cajmns.v7i1.3046

Keywords: myocardial infarction, clinical course, young patients, myocardial revascularization

Abstract

In patients who have suffered a myocardial infarction (MI), heart failure (HF) is caused by a decrease in the pumping function of the heart when a significant portion of the myocardium is activated from contraction. Impairment of the pumping function of the left ventricle of the heart without clinical signs of HF or with minimal, as well as with its pronounced manifestations, on Our opinion should be considered in the aspect of hemodynamic supply to the left ventricles (LV). The New York Heart Association has developed a classification of heart failure into class IV (Stages). At the same time, identifying circulatory decompensation taking into account clinical and angiographic signs is important for assessing the condition of patients and selecting drug therapy. And also when developing indications for surgical correction of this complication.

References

Madjidova G. T., Sunnatova G. I., and Hamidov N. S., “Clinical and hemodynamic conditions and heart natriuretic peptides in the blood plasma of patients with hypertrophic cardiomyopathy,” Eurasian Journal of Medical and Natural Sciences, vol. 2, no. 5, pp. 211–219, 2022.

Khasanjanova F. O. et al., “Evaluation of the effectiveness of thrombolytic therapy in men with acute coronary myocardial infarction in young age,” Central Asian Journal of Medical and Natural Sciences, vol. 2, no. 1, pp. 144–149, 2021.

Khasanzhanova F. O. et al., “Evaluation of the effectiveness of thrombolytic therapy in men with acute myocardial infarction in young age,” Archive of Conferences, vol. 15, no. 1, pp. 48–52, 2021.

Madjidova G. T., Sunnatova G. I., and Usarov S. A., “About the system of treatment of patients with acute coronary syndrome,” Eurasian Journal of Medical and Natural Sciences, vol. 2, no. 5, pp. 197–204, 2022.

Alisherovna S. N. et al., “Course of myocardial infarction in young women,” Eurasian Medical Research Periodical, vol. 7, pp. 106–111, 2022.

Samadova N. A. et al., “Clinical and diagnostic features of myocardial infarction in young patients in emergency medicine,” E-Conference Globe, pp. 16–19, 2021.

Alisherovna S. N. et al., “Clinical and diagnostic features of myocardial infarction in young patients in emergency medicine,” Web of Scientist: International Scientific Research Journal, vol. 2, no. 4, pp. 414–418, 2021.

Samadova N. et al., “Shoshilinch tibbiy yordamda yosh bemorlarda miokard infarktining klinik va diagnostik xususiyatlari,” Zhurnal Kardiorespiratornykh Issledovanii, vol. 2, no. 1, pp. 78–81, 2021.

Alisherovna S. N. et al., “A modern approach to risk stratification in patients with heart failure with preserved and reduced ejection fraction,” Web of Scientist: International Scientific Research Journal, vol. 3, no. 5, pp. 73–81, 2022.

Alisherovna S. N. et al., “Features of the clinical course of unstable angina on the background of COPD,” Web of Scientist: International Scientific Research Journal, vol. 3, no. 5, pp. 82–86, 2022.

Tashkenbaeva E. et al., “Rasprostranennost’ metabolicheskogo sindroma u patsientov s ishemicheskoy bolezn’yu serdtsa,” [Journal not specified], 2021.

Madjidova G., Sunnatova G., and Raimova M., “Protective action metabolic therapies on the coronary circulation at sick acute infarction myocardia,” Science and Innovation, vol. 1, no. D7, pp. 264–273, 2022.

Rakhimova D. Sh. et al., “Early predictors of adverse outcomes in patients with acute myocardial infarction,” European Journal of Molecular and Clinical Medicine, vol. 7, no. 3, pp. 1242–1249, 2020.

Sattorova M. K. et al., “Clinical significance of cardiac biomarkers in diagnosing acute coronary syndromes,” International Journal of Medical Science and Clinical Invention, vol. 8, no. 2, pp. 5237–5243, 2021.

Ismoilov A. T. et al., “Outcomes of primary percutaneous coronary intervention in acute myocardial infarction: experience of a regional cardiology center,” Central Asian Journal of Cardiology, vol. 3, no. 1, pp. 55–63, 2020.